Skip to main content
OpenTrials
Completed

NCT Number: NCT01333163

GLP-1: Acute Effects on Kidney Function in Healthy Men

The purpose of this study is to investigate how Glucagon-Like Peptide 1 (GLP-1) affects kidney function in healthy young men. The hypothesis is that GLP-1 induces a positive effect on kidney hemodynamics.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Kidney Functional

Age range

18 year–30 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Klinisk Institut, Afd. MEA, Aarhus Sygehus, NBG

Aarhus C, 8000, Denmark

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy young men

Exclusion criteria

  • Any chronic diseases

Treatment and study plan

Human GLP-1 (7-36) amide

Biological

2 hour IV infusion, 1,5pmol/min/kg.

Isotone NaCl

Biological

2 hours IV infusion.

Primary outcomes

  1. Glomerular Filtration Rate

    Time frame: Every 20 minutes for 6 hours

Sponsors and collaborators

Lead sponsor

Jeppe Skov

Other

Collaborators

  • Novo Nordisk A/S

Registry information

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Apr 11, 2011
Registry last updated
Dec 15, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.